Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 please find enclosed the press release titled Biocon and Mylan Announce U.S. FDA Approval of Semglee? (insulin glargine injection).
12-Jun-2020
Download PDF
Biocon
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 please find enclosed the press release titled Biocon and Mylan Announce U.S. FDA Approval of Semglee? (insulin glargine injection).
Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds